Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP265215.RAczraviOpfOzjEVpbiceTlS4VKI_Wrm3HbGxKgb1JeG8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP265215.RAczraviOpfOzjEVpbiceTlS4VKI_Wrm3HbGxKgb1JeG8130_assertion type Assertion NP265215.RAczraviOpfOzjEVpbiceTlS4VKI_Wrm3HbGxKgb1JeG8130_head.
- NP265215.RAczraviOpfOzjEVpbiceTlS4VKI_Wrm3HbGxKgb1JeG8130_assertion description "[Nearly half of these tumors are nonhyperdiploid and mostly have immunoglobulin H (IgH) translocations that involve 5 recurrent chromosomal loci, including 11q13 (cyclin D1), 6p21 (cyclin D3), 4p16 (fibroblast growth factor receptor 3 [FGFR3] and multiple myeloma SET domain [MMSET]), 16q23 (c-maf), and 20q11 (mafB).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP265215.RAczraviOpfOzjEVpbiceTlS4VKI_Wrm3HbGxKgb1JeG8130_provenance.
- NP265215.RAczraviOpfOzjEVpbiceTlS4VKI_Wrm3HbGxKgb1JeG8130_assertion evidence source_evidence_literature NP265215.RAczraviOpfOzjEVpbiceTlS4VKI_Wrm3HbGxKgb1JeG8130_provenance.
- NP265215.RAczraviOpfOzjEVpbiceTlS4VKI_Wrm3HbGxKgb1JeG8130_assertion SIO_000772 15090448 NP265215.RAczraviOpfOzjEVpbiceTlS4VKI_Wrm3HbGxKgb1JeG8130_provenance.
- NP265215.RAczraviOpfOzjEVpbiceTlS4VKI_Wrm3HbGxKgb1JeG8130_assertion wasDerivedFrom befree-20140225 NP265215.RAczraviOpfOzjEVpbiceTlS4VKI_Wrm3HbGxKgb1JeG8130_provenance.
- NP265215.RAczraviOpfOzjEVpbiceTlS4VKI_Wrm3HbGxKgb1JeG8130_assertion wasGeneratedBy ECO_0000203 NP265215.RAczraviOpfOzjEVpbiceTlS4VKI_Wrm3HbGxKgb1JeG8130_provenance.